Next, we compared the antitumor effects of anti‐PD‐L1 treatment with various other cancer therapeutics, including cisplatin, one of the most widely used chemotherapeutics, and DC101, a potent anti‐angiogenic agent, by VEGFR2 blockade. Here, KDR is linked to cancer.